RecruitingNCT02241265
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
Sponsor
University of Oklahoma
Enrollment
20 participants
Start Date
Feb 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- \>18 years of age
- severe asthma diagnosis
- decreased FEV1
Exclusion Criteria1
- \< 18 years of age
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02241265
Related Trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267393 locations
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619138 locations
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT047069881 location
To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong
NCT046397911 location
Use of Biologics for Severe Asthma in Hong Kong
NCT067787461 location